Toggle navigation
Home
Search
Services
Blog
Contact
About
Isolation and Study of New Mammalian DNA Repair Enzyme
Toney, Jeffrey Howard
Dana-Farber Cancer Institute, Boston, MA, United States
Search 4 grants from Jeffrey Toney
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
LAMBdA: The Latin American Mortality Database
Cctn - Male Contraceptive - Dmau 28 Day Study
Structural insight into novel mechanisms of type III secretion
Control of Sterol and Lipoprotein Homeostasis by miRNA
Synthesis of Batrachotoxin and Other Complex Heterocycle
Recently added grants:
Indigenous Trauma & Resilience Research Center
Indigenous Trauma & Resilience Research Center- Administrative Core
Community Engagement O Core
Human Subject Core
Historical trauma and resilience as a biological state and its association with the effects of the traditional Indigenous food chokeberry
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32CA007951-02
Application #
3032929
Study Section
(BI)
Project Start
1987-01-01
Project End
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1987
F32 CA
Isolation and Study of New Mammalian DNA Repair Enzyme
Toney, Jeffrey Howard / Dana-Farber Cancer Institute
NIH 1985
F32 CA
Isolation and Study of New Mammalian DNA Repair Enzyme
Toney, Jeffrey Howard / Dana-Farber Cancer Institute
Publications
Toney, J H; Donahue, B A; Kellett, P J et al.
(1989)
Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II)
Proc Natl Acad Sci U S A 86:8328-32
Comments
Be the first to comment on Jeffrey Toney's grant